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Abstract
Background/Aims: The extracellular calcium-sensing receptor (﴾CaR)﴿ is expressed in 
pancreatic -cells where it is thought to facilitate cell-to-cell communication and augment 
insulin secretion. However, it is unknown how CaR activation improves -cell function. 
Methods: Immunocytochemistry and western blotting confirmed the expression of CaR in 
MIN6 -cell line. The calcimimetic R568 (﴾1µM)﴿ was used to increase the affinity of the CaR 
and specifically activate the receptor at a physiologically appropriate extracellular calcium 
concentration. Incorporation of 5-bromo-2’-deoxyuridine (﴾BrdU)﴿ was used to measure cell 
proliferation, whilst changes in non-nutrient-evoked cytosolic calcium were assessed using 
fura-2-microfluorimetry. AFM-single-cell-force spectroscopy related CaR-evoked changes in 
epithelial (﴾E)﴿-cadherin expression to improved functional tethering between coupled cells. 
Results: Activation of the CaR over 48hr doubled the expression of E-cadherin (﴾206±41%)﴿ 
and increased L-type voltage-dependent calcium channel expression by 70% compared to 
control. These changes produced a 30% increase in cell-cell tethering and elevated the basal-
to-peak amplitude of ATP (﴾50µM)﴿ and tolbutamide (﴾100µM)﴿-evoked changes in cytosolic 
calcium. Activation of the receptor also increased PD98059 (﴾1-100µM)﴿ and SU1498 (﴾1-100µM)﴿-
dependent -cell proliferation. Conclusion: Our data suggest that activation of the CaR 
increases E-cadherin mediated functional tethering between -cells and increases expression 
of L-type VDCC and secretagogue-evoked changes in [Ca2+]i. These findings could explain 
how local changes in calcium, co-released with insulin, activate the CaR on neighbouring cells 
to help ensure efficient and appropriate secretory function.
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The   extracellular   calcium   sensing   receptor   (CaR)  plays   a   central   role   in  maintaining  
systemic  Ca2+-­‐homeostasis  by  regulating  the  secretion  of  parathyroid  hormone  and  urinary  
calcium   concentration   [1].   However,   since   the   identiϐication   and   characterisation   of   the  
receptor   [2],   it   has   become   increasingly   apparent   that   this   cationic   ion   binding   receptor  
is   found   on   many   tissues   not   associated   with   the   control   of   plasma   [Ca2+]   including;  
oesophageal   [3]   and   colonic   epithelia   [4],   the   cardiovascular   system   (reviewed   in   [5]),  
hypothalamic  neurons   [6],  pancreatic  ducts   [7]   and  pancreatic  -­‐   and  -­‐cells   [8-­‐10].  The  
functional  signiϐicance  of  the  CaR  in  tissue  not  involved  in  the  control  of  systemic  Ca2+  is  not  
fully  understood  [11,  12].  In  exocrine  pancreas  it  has  been  suggested  that  the  CaR  monitors  
extracellular  Ca2+  in  pancreatic  juice  to  limit  the  risk  of  Ca2+  carbonate  stone  formation  [13],  
whilst  the  receptor  may  detect  changes  in  levels  of  dietary  Ca2+  in  gastrin  secreting  cells  of  
the  human  antrum  [14-­‐16].  However,  a  more  global  explanation  for  the  role  of  the  CaR  in  
these  disparate  tissues  could  be  in  its  ability  to  detect  local  ϐluctuations  in  Ca2+,  mediating  
cell-­‐cell  coupling,  communication  and  function.  
The   possibility   that   local   changes   in   extracellular   Ca2+   resulting   from   the   efϐlux   of  
mobilised  Ca2+  in  one  cell  are  sufϐicient  to  activate  the  CaR  on  an  adjacent  cell  was  elegantly  
demonstrated   in   a  model   system  of   the  kidney  epithelium   [17].   In   this  novel   study,  Ca2+-­‐
extrusion   from   ϐibroblasts   was   shown   to   activate   the   CaR   on   co-­‐cultured   HEK   cells   to  
elicit  a  response  [18].  In  the  pancreas,  cell-­‐to-­‐cell  communication  improves  the  functional  
responsiveness  of  cells  and  augments   insulin  secretion   [19,  20].  Speciϐic  activation  of   the  
CaR  using  calcimimetics  [21]  enhances  insulin  secretion  from  human  islets  [10].  Secretory  
granules  contain  high  concentrations  of  Ca2+  which  is  released  upon  exocytosis  [22].  Recently  
Ca2+-­‐sensitive  microelectrodes  have  been  used  to  demonstrate  that  the  extracellular  spaces  
surrounding  -­‐cells  constitute  a  restricted  domain  where  Ca2+,  co-­‐released  during  exocytosis  
reaches  millimolar  concentrations  [23].  These  direct  measurements  support  the  concept  of  
local  ‘hot-­‐spots’  of  extracellular  Ca2+  which  are  able  to  activate  the  CaR  on  neighbouring  -­‐
cells.
The  use  of  calcimimetics  to  speciϐically  activate  the  CaR  by  increasing  receptor  afϐinity  
for  its  ligand  avoids  the  many  non-­‐speciϐic  eﬀects  observed  when  using  supra-­‐physiological  
changes  in  calcium  concentration.  Activation  of  the  CaR  in  -­‐cells  is  associated  with  rapid  
increases  in  cytoslic  calcium  and  marked,  but  transient,  increases  in  insulin  secretion  [24,  
25].  Our  earlier  work  suggests  that  the  CaR  can  mediate  cell-­‐to-­‐cell  communication  within  
islets;  however,  how  this  communication  is  facilitated  has  yet  to  be  resolved.  In  the  present  
study  we  conϐirm  CaR  expression   in  our  model  of  homotypic  -­‐cell-­‐-­‐cell   interaction  and  
provide   compelling   evidence   that   activation   of   the   receptor   increases   expression   of   the  
epithelial   (E)   adhesion  protein  E-­‐cadherin  and   increases   functional   tethering  between  -­‐
cells.  These  data  could  explain  why  the  secretory  efϐiciency  of  the  intact  islet  is  far  greater  
than  the  sum  of  its  composite  -­‐cells  when  studied  in  isolation.
Materials and Methods
Materials
MIN6   cells  were   obtained   from  Dr.   Y.Oka   and   J.-­‐I.  Miyazaki   (Univ.   of   Tokyo,   Tokyo,   Japan).   DMEM,  
glutamine,  penicillin-­‐streptomycin,  gelatin  (from  bovine  skin),  PBS,  foetal  bovine  serum  and  trypsin-­‐EDTA  
were  from  Sigma-­‐Aldrich  (Poole,  Dorset,  UK).  Tissue  culture  media  and  plasticware  were  from  Invitrogen  
Life  Technologies  (Paisley,  UK).  Immobilon  P  membranes  (Millipore,  Watford,UK),  ECL  detection  reagents  
(Amersham  Biosciences,  Buckinghamshire,  UK).  Anti-­‐fade  Citiϐluor  (glycerol/PBS  solution:  Agar  Scientiϐic,  
Essex,  UK).  The  MEK  inhibitor  PD98059  and  the  inhibitor  of  VEGF  receptor  2,  SU1498,  that  inhibits  ERKs  
phosphorylated  by  growth   factors,were   from  Calbiochem  (Nottingham,  UK).  The  calcimimetic  R568  was  
from  Amgen  Inc  (Thousand  Oaks,  CA,  USA).  BrdU,  Alexa  secondaries  and  Alexa  Fluor  594  conjugated  anti-­‐
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BrdU  were  from  Invitrogen  (Molecular  Probes,  Eugene,  Oregon,  USA).  Antibodies  were  obtained  from  Santa  
Cruz  (CA,  USA)  and  Sigma-­‐Aldrich  (Poole,  Dorset,  UK).
Maintenance  of  MIN6  cells  
MIN6  cells  (passasge  35-­‐40)  were  maintained  at  37°C  (95%  air/5%  CO2)  in  DMEM  supplemented  with  
15%  foetal  calf  serum  (FCS),  2mM  glutamine  and  100U/ml  penicillin/0.1mg/ml  streptomycin  (all  Sigma  
Chemical  Co.  Poole,  Dorset).  Cells  were  split  when  80%  conϐluent,  about  every  3-­‐4  days  using  Trypsin-­‐EDTA.  
Prior  to  treatment,  cells  were  placed  in  fresh  DMEM  containing  glucose  (5mmol/l)  and  low  calcium  (0.5mM)  
overnight.
Immunoblotting  
Whole-­‐cell  proteins  were  prepared  and  separated  by  SDS-­‐PAGE  and  electroblotted  onto  Immobilon  
P  membranes  as  described  previously   [26].  Membranes  were  probed  with  polyclonal  antibodies  against  
human   -­‐catenin   (Santa   Cruz   Biotechnology),   raised   against   amino   acids   680-­‐781   mapping   at   the   C-­‐
terminus   of  -­‐catenin,  mouse   E-­‐cadherin   (Sigma  UK   product   code  U3254-­‐anti-­‐uvomorulin),  mouse   CaR  
raised  against  a  synthetic  peptide  corresponding  to  residues  18-­‐29  of  the  mouse  CaR  (CSAYGPDQRAQKK;  
Genosphere  Biotechnologies,  Paris-­‐France)  and  human  L-­‐Type  voltage  gated  calcium  channel  (Santa  Cruz  
Biotechnology)  raised  against  amino  acids  1661-­‐1900  mapping  within  an  internal  region  of  L-­‐type  Ca2+  CP  
1D  at  dilutions  of  1:5000,  1:500,  1:1000,  and  1:500  respectively  in  PBS,  0.05%  Tween-­‐20.  After  three  10-­‐
min  washes  (PBS,  0.1%  Tween  20),  membranes  were  incubated  with  the  following  secondary  antibodies  
(horseradish  peroxidase-­‐conjugated),  anti-­‐rat  (E-­‐Cadherin  diluted  1:20,000  in  PBS,  0.05%  Tween-­‐20),  and  
anti-­‐rabbit  secondary  (L-­‐Type  Voltage  gated  calcium  channel,  -­‐catenin  and  CaR  all  diluted  at  1:40,000  in  
PBS,  0.05%  Tween-­‐20)  for  60  min  at  25°C  followed  by  three  10-­‐min  washes  (PBS,  0.1%  Tween  20).  Proteins  
were   visualized   using   enhanced   chemiluminescence   and   exposure   to   ϐilm.   Blots   were   stripped   and   re-­‐
probed  with  anti-­‐rabbit  glyceraldehyde-­‐3-­‐phosphate  dehydrogenase  (GAPDH)  (1:20,000;  R&D  Systems)  to  
control  for  protein  loading  in  subsequent  densitometry  analysis.
Immunocytochemistry  
Cells  at  80%  conϐluence  were  ϐixed  with  4%  paraformaldehyde  (PFA).  Following  blocking,  the  nuclear  
stain  4’,  6-­‐diamidino-­‐2-­‐phenylindole,  dihydrochloride  (DAPI;  1mM)  was  added  for  3mins.  Cells  were  then  
incubated   with   antibodies   against   anti-­‐   E-­‐cadherin   (Sigma),   CaR   (Genosphere   Biotechnologies,   Paris-­‐
France),  -­‐catenin  (Santa  Cruz),  and  L-­‐Type  voltage  gated  calcium  channel  (Santa  Cruz)  diluted  at  1:100  
in   PBS-­‐Triton   overnight   at   4°C.   Candidate   proteins   were   visualized   using   Alexa488   or   594-­‐conjugated  
secondary  antibodies  (1:1,000)  in  PBS-­‐Triton  for  1hr  at  25°C.  Fluorescence  was  visualized  using  an  Axiovert  
200  ϐluorescence  microscope  (Carl  Zeiss,  Welwyn  Garden  City,  UK).
Calcium  Microϔluorimetry
MIN6   cells   were   transferred   to   APES-­‐coated   coverslips   and   allowed   to   adhere   overnight   under  
standard  tissue  culture  conditions.  Cells  were  then  either  maintained  in  control  media  or  cultured  in  with  
R568  (1µM)  for  48hrs.  To  determine  agonist-­‐evoked  changes  in  cytosolic  calcium,  cells  were  loaded  for  30  
minutes  in  5mM  glucose  at  37°C  with  5µM  Fura-­‐2/AM  (Sigma,  UK).  Washed  coverslips  formed  the  base  of  a  
stainless  steel  bath  placed  into  a  heating  platform  on  the  microscope  stage  (Axiovert  200  Research  Inverted  
microscope,  Carl  Zeiss  Ltd.,  Welwyn  Garden  City,  UK).  All  experiments  were  carried  out  at  37°C  using  a  Na+-­‐
rich  balanced  salt  solution  as  the  standard  extracellular  medium  (137mM  NaCl,  5.4mM  KCl,  1.3mM  CaCl2,  
0.8mM  MgSO4,  0.3mM  Na2HPO4,  0.4mM  KH2PO4,  4.2mM  NaHCO3,  10mM  HEPES  and  5mM  glucose,  pH  7.4).  
A  low-­‐pressure  rapid-­‐superfusion  system  (ϐlow  rate  1-­‐2ml/min)  was  used  to  change  the  solutions  in  the  
bath  to  allow  for  the  acute  addition  of  the  non-­‐nutrient  secretagogues  ATP  (50µM),  tolbutamide  (100µM)  
and   KCl   (20mM).   Cells  were   illuminated   alternatively   at   340nm   and   380nm   using   a  Metaϐlour   imaging  
workbench   (Universal   Imaging  Corp  Ltd.,  Marlow,  Bucks,  UK).  Emitted   light  was   ϐiltered  using  a  510nm  
long-­‐pass  barrier  ϐilter  and  detected  using  a  Cool  Snap  HQ  CCD  camera  (Roper  Scientiϐic).  Data  was  collected  
at  3-­‐second  intervals  for  multiple  regions  of  interest  in  any  one  ϐield  of  view.  All  records  have  been  corrected  
for  background  ϐluorescence  (determined  from  cell-­‐free  coverslip).
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DNA  synthesis  as  a  marker  of  cell  proliferation  was  assessed  by  measuring  the  incorporation  of  5-­‐bromo-­‐
2’-­‐deoxyuridine  (BrdU)  in  individual  cells  using  micro-­‐ϐluorimetric  localisation  of  BrdU-­‐immunoreactivity  
as  described  previously  [27].  Brieϐly,  MIN6  cells  were  seeded  onto  3-­‐aminopropyl-­‐triethoxysilane  (APES)  
treated   cover   glass   at   a  density  of  30,000   cells/well   and   left   to   adhere  overnight  under   standard   tissue  
culture  conditions  (95%  air/5%  CO2,  37°C)  in  DMEM  supplemented  with  15%  FCS.  Cells  were  then  washed  
in   sterile   PBS   and   serum   starved   overnight   in   fresh  DMEM   containing   glucose   (5mM)   and   low   calcium  
(0.5mM).  As  required,  PD98059  [27]  or  SU1498  [28]  were  applied  as  a  1hr  pre-­‐treatment,  before  adding  
the   incubation  media  containing,   calcium  (0-­‐10mM),   calcimimetic   (+/-­‐R568   (1µM))  and  +/-­‐PD98059  or  
SU1498  (1-­‐100µM).  All  solutions  contained  BrdU  (10µM)  for  the  ϐinal  2hr  incubation.  Cells  were  ϐixed  with  
4%  paraformaldehyde  (PFA)  and  their  DNA  denatured  using  1M  HCl  (30min  at  RT)  before   incubating   in  
Alexa-­‐594-­‐conjugated   anti-­‐BrdU   (Molecular   Probes,   Invitrogen)   at   1:200   and   storing   overnight   at   4°C.  
After  repeated  washing  (PBS  /triton  (0.01%))  BrdU  incorporation  was  determined  using  an  Axiovert  200  
inverted  ϐluorescent  microscope  (Carl  Zeiss,  Welwyn  Garden  City,  UK).  Six  diﬀerent  wells  in  three  separate  
experiments  were  used  for  each  treatment  and  the  number  of  BrdU-­‐positive  cells  compared  to  non-­‐BrdU-­‐
immunoreactive  cells,  determined  for  several  (4-­‐6)  arbitrary  regions/well  in  3-­‐4  separate  experiments.
Single  cell  force  spectroscopy  
Atomic   force   microscopy-­‐single-­‐cell   force   spectroscopy   (AFM-­‐SCFS)   was   carried   out   using   the  
CellHesion®200   module   (JPK   Instruments,   Berlin,   Germany)   installed   on   an   Eclipse   TE   300   inverted  
microscope  (Nikon,  USA).  The  BioCell™   temperature  controller   (JPK,  Berlin,  Germany)  was   incorporated  
into  the  stage  of  the  microscope  so  that  all  force  spectroscopy  measurements  were  performed  at  a  constant  
temperature  of  37°C.  The  entire  system  was  placed  on  top  of  an  anti-­‐vibration  table  (TMC  63-­‐530,  USA).  As  
described  previously  [29],   tipless  Arrow  TL-­‐1  cantilevers  (NanoWorld,  Switzerland),  with   force  constant  
0.03N/m,  were  coated  with  poly-­‐L-­‐lysine  (25µg/ml  in  PBS,  30min,  RT)  and  then  ϐibronectin  (20µg/ml  in  PBS,  
2hr,  37°C),  in  order  to  capture  a  single  suspended  cell.  Prior  to  cell  attachment,  a  single  Force-­‐Displacement  
(F-­‐D)   curve  was   conducted   to   calibrate   the   instrument,   using   the   thermal   ϐluctuation  method   for   ϐluids  
(JPK  Software  Release  3.4,  Berlin,  Germany).  Subsequently,  SCFS  was  conducted  by  bringing  the  cantilever-­‐
bounded  cell  into  contact  with  an  adherent  substrate  cell  until  a  determined  force  (0.8nN)  is  reached.  The  
two  cells   remained   in  contact   for  a  set  period  of   time  (5sec),  while  bonding   formed.  The  cantilever  was  
then  retracted  at  a  constant  speed  (5µm/sec)  and  force  (nN)  versus  displacement  (µm)  was  continuously  
measured  until   the  cells  were  completely   separated.  For  each  cell,   three  successive  measurements  were  
performed   with   30sec   interval   pause.   F-­‐D   measurements   from   multiple   cells   (approx   40)   in   separate  
experiments  (n=4)  were  completed  and  the  maximum  unbinding   force  (nN)  and  the  detachment  energy  
(fJoules)  calculated.
Data  Analysis
Autoradiographs   were   quantiϐied   by   densitometry   using   TotalLab   2003   (NonLinear   Dynamics,  
Durham,  NC  USA).  In  all  experiments  where  data  was  quantiϐied,  the  control  condition  was  normalized  to  
100%  and  data   from  all  other  experimental  conditions  compared  to   this.  Statistical  analysis  of  data  was  
performed  using  either  a  paired  t-­‐test  or  a  one-­‐way  ANOVA  test  with  a  Tukey’s  multiple  comparison  post-­‐
test.  Data  are  expressed  as  mean  +  SEM,  and  ‘n’  denotes  the  number  of  experiments.  P<0.05  was  taken  to  
signify  statistical  signiϐicance.  All  statistical  analyses  were  performed  using  the  Prism  GraphPad  software  
version  4.0  (San  Diego,  CA,  USA).  
Results
MIN6  cells  express  the  CaR  and  adherens  junction  proteins
Western  blot  analysis  conϐirmed  expression  of  (A)  E-­‐cadherin,  (B)  -­‐catenin,  (C)  CaR  
and  (D)  L-­‐type  VDCC  in  3  separate  preparations  of  MIN6  cells,  giving  rise  to  bands  at  120kDa,  
97kDa,   130kDa   and   200kDa   respectively   (Fig.   1).   The   distribution   of   each   protein   was  
examined  by  immunocytochemistry.  E-­‐cadherin,  -­‐catenin  and  the  CaR  exhibited  membrane  
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and  cytosolic  localisation,  whilst  the  L-­‐type  VDCC  appeared  more  diﬀusely  spread  throughout  
all  cell  compartments.
Activation  of  the  CaR  increases  the  expression  of  E-­cadherin  and  L-­type  VDCCs
MIN6   cells   were   incubated   for   48hrs   in   low   glucose   (5mmol/l)   with   increasing  
concentrations  of   extracellular   calcium   (nominal-­‐no  added  calcium,  0.5,  5   and  10mM)  or  
0.5mM  calcium  ±   the  active   (R)  or   inactive   (S)   stereo-­‐isomers  of  568   (1µM).  Over  48hrs,  
supra-­‐physiological   increases   in   [Ca2+]e,   or   addition   of   the   less   active   S568   isomer   of   the  
calcimimetic,  failed  to  alter  the  expression  of  any  the  candidate  proteins.  Conversely,  speciϐic  
targeting  of  the  CaR  by  R568  increased  whole–cell  expression  of  E-­‐cadherin  by  206±41%  of  
control  (n=4;  P<0.05,  Fig.  2A)  and  up-­‐regulated  expression  of  the  L-­‐type  VDCC  to  174±10%  
(n=4;  P<0.05)  of  control  (Fig.  2D),  but  failed  to  alter  the  expression  of  -­‐catenin  (Fig.  2B)  or  
the  CaR  itself  (Fig.  2C).  The  changes  in  E-­‐cadherin  and  L-­‐type  VDCC  were  not  observed  at  
earlier  time  points  (e.g.  12  and  24hrs;  data  not  shown).
Activation  of  the  CaR  increases  adherence  between  coupled  -­cells
In   order   to   relate   the   change   in   expression/localisation   of   E-­‐cadherin   to   functional  
tethering,   atomic   force   microscopy-­‐single-­‐cell-­‐force   spectroscopy   (AFM-­‐SCFS)   was   used  
to  measure   cell-­‐cell   adhesion   and   the   separation   forces   required   to   uncouple   cells.   Prior  
to  attachment,  cells  were  cultured  for  48hrs  under  identical  conditions  +/-­‐R568  (1µM).  A  
single  MIN6  cell  (cell-­‐1)  was  bound  to  a  cantilever  and  subsequently  brought  into  contact  
with  an  adherent  cell   (cell-­‐2)  within  a  cluster,  using  a   ϐixed   force   (Fig.  3A  phase   inserts).  
After   5sec,   the   cantilever   was   then   retracted   (5µm/sec)   and   force   versus   displacement  
measured  until  the  cells  were  completely  separated.  Retraction  force-­‐displacement  curves  
Fig. 1.  MIN6  cells  express  the  CaR  
and   adherens   junction   proteins.  
Western   blot   analyses   of   MIN6  
cell   lysates   (5g   protein/lane)  
using   antibodies   against   mouse  
(A)   E-­‐cadherin,   (B)   -­‐catenin,  
(C)   CaR,   and   (D)   L-­‐type   VDCC  
detected   appropriate   bands   of  
approximately   120kDa,   97kDa,  
130kDa   and   200kDa   respectively.  
Controls   included   antibody   pre-­‐
absorbed   with   a   10-­‐fold   excess  
of   immunizing   peptide   (data   not  
shown).   Immunocytochemistry  
conϐirmed  that  each  of  the  proteins  
studied   exhibited   membrane   and  
cytosolic  localization.
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provide  important  information  regarding  the  adhesion  between  two  cells,  such  as  the  energy  
required  to  separate  them  (the  grey  area  in  panel  A),  and  maximum  force  of  detachment  (red  
circle).  The  former  is  normally  referred  to  as  “detachment  energy”  (panel  C)  and  the  latter  
the  “maximum  unbinding  force”  (panel  B).  The  retraction  measurements  of  control  (38cells  
in  4  separate  experiments)  and  R568-­‐treated  MIN6  cells  (43cells  in  4  separate  experiments)  
are   shown   in   the   ϐigure   3B   &   C.   The   results   indicate   that   the   calcimimetic   R568   (1µM)  
increases  the  maximum  unbinding  force  by  29±3.1%  (n=4;  P<0.001),  whilst  the  detachment  
energy,  or  the  total  energy  (fJoules)  required  to  uncouple  cells   following  R568  treatment,  
was  increased  31±3.9%  (n=4;  P<0.001).
Fig. 2.  Activation  of   the  CaR   increases  expression  of  E-­‐cadherin  and  L-­‐type  VDCC.  MIN6  were  grown   in  
low  glucose  (5mmol/l)  +/-­‐  calcium  (5  or  10mM)  or  calcium  (0.5mM)  +/-­‐  R568  or  S568  (1µM)  for  48hrs  
and  whole  cell  expression  of  (A)  E-­‐cadherin,  (B)  -­‐catenin,  (C)  CaR  and  (D)  L-­‐type  VDCC  was  determined  
by   immunoblotting.  Upper  panels   show   representative  blots   for   each  protein   and   re-­‐probed   for  GAPDH  
as   a   loading   control.   Lower   panels   show  mean   (±SEM)   densitometry   data,   normalised   against   the   non-­‐
stimulated  low  glucose,  nominal  calcium  control  (100%),  from  3  or  more  separate  experiments.  Each  bar  
in  the  histogram  corresponds  to  the  associated  lane  in  the  representative  blot.  Key  signiϐicances  are  shown,  
*P<0.05.
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Activation  of   the  CaR  alters   the  amplitude  of  non-­nutrient-­evoked   [Ca2+]i   oscillations   in  
-­cells
G-­‐protein  coupled  receptors,  such  as  the  P2-­‐purinoreceptors,  are  important  modulators  
of  -­‐cell  function,  whilst  sulphonylureas  (such  as  tolbutamide)  stimulate  insulin  secretion  
by   closing   the  ATP-­‐sensitive  K+-­‐channels   (K+ATP)   leading   to  membrane  depolarization  and  
Ca2+-­‐entry.  To  relate  the  CaR-­‐evoked  change  in  protein  expression  of  E-­‐cadherin  and  L-­‐type  
VDCC,  the  eﬀects  of  chronic  activation  of  the  CaR  on  these  non-­‐nutrient  evoked  changes  in  
[Ca2+]i  were  examined.  In  ϐigure  4,  the  eﬀects  of  ATP  (50M),  Tolbutamide  (100M)  and  KCl  
(20mM)  on  changes  in  [Ca2+]i  from  MIN6  cells  cultured  in  R568  (48hrs,  1µM)  in  low  glucose  
(5mmol/l)  is  determined.  Figure  4A  is  a  representative  trace  from  3  regions  (cells)  in  a  single  
experiment  (R1-­‐3)  showing  that  ATP,  tolbutamide  and  KCl  evoked  increases  in  intracellular  
calcium  in  both  control  and  R568-­‐treated  cells  (in  a  total  of  ϐive  separate  experiments).  The  
basal-­‐to-­‐peak  change  in  [Ca2+]i  induced  by  ATP  and  tolbutamide  were  respectively  increased  
to  164±19%  and  161±12%  of  control  (n=3;  P<0.05).  The  calcimimetic  failed  to  signiϐicantly  
alter  the  basal-­‐to-­‐peak  KCl  response.  
Activation  of  the  CaR  increases  MAPK-­dependent  proliferation
MIN6  cells  were  incubated  in  0.5mM  [Ca2+]e  ±  R568  (48hrs,  1µM)  and  BrdU-­‐incorporation  
was   used   to   determine   cell   proliferation   (Fig.   5A).   Low   extracellular   calcium   (0.5mM)  
increased  proliferation  compared  to  nominal  calcium  conditions  (154%±12%).  This  increase  
in   proliferation  was   enhanced   in   the   presence   of   R568   (218±37%   compared   to   nominal  
calcium  control,  n=3  P<0.05,  Fig.  5B).   It  has  been  previously  reported  that  p42/44  MAPK  
are  active  in  non-­‐stimulated  MIN6  cells.  In  a  separate  series  of  experiments,  the  R568  (1µM)  
signiϐicantly   increased  proliferation  by  171±18%  as   compared   to  0.5mM  Ca2+-­‐alone   (n=3  
P<0.01).  This  CaR-­‐evoked   increase   in  cell   turnover  was  dramatically  reduced  to  29±5.1%  
Fig. 3.   Activation   of   the   CaR   reduces  
functional   tethering.   AFM-­‐force   spectro-­‐
scopy  was  used  to  measure  the  detachment  
energy  (fJoules)  and  maximum  unbinding  
force  (nN)  required  to  uncouple  two  MIN6  
cells.  In  panel  A,  a  single  MIN6  cell  can  be  
seen  bound  to  the  cantilever  (cell-­‐1,  phase  
insert).  This  was  bought  into  contact  with  
an  adherent  cell-­‐2  using  a  ϐixed  force  (1nN)  
for   10sec,   whilst   bonding   formed.   The  
cantilever   was   then   retracted   (5µm/sec)  
and   force   versus   displacement  measured  
until   the   cells   separated   (approximate  
pulling   length   10-­‐30µm).   The   energy  
required  to  separate  the  cells  (grey  area  in  
panel  A),  and  maximum  force  of  detachment  
(red   circle)  was  measured.   The   former   is  
known  as  the  “detachment  energy”  (panel  
C)   and   the   later   is   “maximum   unbinding  
force”   (panel   B).   The   calcimimetic   R568  
(1µM)  increased  the  maximum  unbinding  
force  by  29%,  and  the  detachment  energy  
increased   by   31%   compared   to   control.  
Data   is   expressed   as   mean   ±   SEM.   of  
multiple  cells  from  4  separate  experiments,  
where   key   signiϐicances   are   shown,  
***  P<0.001.
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Fig. 4.   Activation   of   the  
CaR   increases   ATP   and  
To l b u t am i d e -­‐ e v o k e d  
changes   in   [Ca2+]i.   In   panel  
A,  ATP  (50M),  tolbutamide  
(100M)   and  KCl   (20mM)-­‐
evoked  changes  in  [Ca2+]i  in  
MIN6  cells  +/-­‐  R568  (1µM).  
The  calcimimetic  altered  the  
proϐile  of  the  response  to  the  
non-­‐nutrient  secretagogues  
and  increased  the  basal-­‐to-­‐
peak  amplitude  to  ATP  and  
the   sulphonylurea   (panel  
B).  There  was  no  signiϐicant  
change   in   the  amplitude   to  
KCl   in   response   to   R568.  
Key   signiϐicances   are  
shown,  *P<0.05.
and   7±2%   of   the   low   calcium   control   by   both   PD98059   (100µM)   and   SU1498   (100µM)  
respectively  (n=3  P<0.001,  see  Fig.  5C).  In  a  further  series  of  experiments  (n=4),  inhibition  
was  found  to  be  concentration-­‐dependent  with  1µM,  10µM  and  100µM  PD98059  reducing  
proliferation  to  86±10%,  52±1%  (P<0.01),  and  11±11%  (P<0.001)  of  0.5mM  calcium  alone,  
whilst  1µM,  10µM  and  100µM  SU1498  inhibited  basal  -­‐cell  turnover  by  52±12%  (P<0.01),  
43±6%  (P<0.01),  and  3±3%  (P<0.001)  respectively,  data  not  shown.
Discussion
Cadherins   are   important   in   forming   the   multi-­‐protein   adherens   junction   (AJ)   that  
links  cell-­‐cell  contact   to  the  actin  cytoskeleton  and  various  signalling  molecules  [30].  The  
extracellular   domain  mediates   ligation  with  E-­‐cadherin   on   adjacent   cells   [31],  whilst   the  
cytoplasmic   domain   binds   to  -­‐catenin   linking   cadherin   to   the   actin   cytoskeleton   via  -­‐
catenin.   Interaction  of  cadherin  with  F-­‐actin,  via   the  catenins,  not  only  serves   to   increase  
adhesive  strength  of  the  junction  but  also  acts  as  a  signalling  ‘node’  for  proteins  that  inϐluence  
adhesiveness   &/or   initiate   intracellular   signalling.   Co-­‐localised   with   ECAD   and   CAT   at  
the   sites   of   cell-­‐cell   contact,   connexins   (Cx)   oligomerise   into   hexameric   hemichannels  
(connexons)   connecting   the   cytoplasm   of   adjoining   cells   and   forming   gap   junctions   (GJ).  
These  GJs  allow  transfer  of  solutes,  metabolic  precursors  and  electrical  currents  [32],  and  
are  essential  for  synchronising  activity  across  the  bulk  mass  of  the  islet  to  ensure  eﬀective  
and  appropriate  secretion  [33].  Inhibiting  cadherin-­‐based  cell  adhesion  inhibits  GJ-­‐assembly  
[34],  whilst  expression  of  recombinant  cadherins  into  cells  lacking  strong  coupling,  increases  
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Fig. 5.  Activation  of  the  CaR  increases  MAPK-­‐
dependent  cell  proliferation.  Cell  proliferation  
was   determined   by   the   incorporation   of   5-­‐
bromo-­‐2’-­‐deoxyuridine   (BrdU)   into   MIN6  
DNA   and   visualized   by   ALEXA   594-­‐tagged  
anti-­‐BrdU   (red   cells,   representative   panel  
A).   Data   represent   cell   counts   from   4-­‐6  
arbitrary   regions   (10-­‐50cells/region)   from  
3-­‐4   repeat   slides   in   3   separate   experiments.  
All   data   were   recorded   in   the   absence   of  
FCS   and   expressed   as   a   %   of   a   nominal  
Ca2+   control   (panel   B).   Small   increases   in  
proliferation   induced  by   low   [Ca2+]e   (0.5mM)  
were   signiϐicantly   increased   by   R568   (1µM).  
Inhibition  of  the  p42/44  MAPK  pathway  using  
the   MEK   inhibitor   PD98059   (100µM)   or  
SU1498   (100µM)   reduced   proliferation  
by   71%   and   93%   respectively   (C).  
Key   signiϐicances   are   shown   where  
**   P<0.01,   ***   P<   0.001   for   3   separate  
experiments.
Cx-­‐phosphorylation   at   the   AJ   [35]   and   increases   cell-­‐to-­‐cell   communication   [36].   Since  
intercellular  adhesion  precedes  GJ-­‐formation  and   inhibiting  cadherin-­‐based  cell   adhesion  
inhibits  GJ-­‐assembly,  we  hypothesize   that   a   gain   in   cell-­‐cell   adhesion  will   have  beneϐicial  
eﬀects  on  -­‐cell  function.
There   is   considerable   evidence   suggesting   that   the   extracellular   calcium-­‐sensing  
receptor  (CaR)  can  mediate  cell-­‐to-­‐cell  communication  within  the  pancreatic  islet  [8,  10,  24,  
25];  however,  how  this  communication  is  facilitated  has  yet  to  be  resolved.  In  the  present  
study  we  conϐirm  CaR  expression   in  our  model  of  homotypic  -­‐cell-­‐-­‐cell   interaction  and  
report   that   chronic   activation   of   the   receptor   increases   expression   of   the   epithelial   (E)  
adhesion  protein  E-­‐cadherin.  Furthermore,  using  single-­‐cell  force-­‐spectroscopy  we  present  
novel  data  conϐirming  that  the  CaR-­‐evoked  increase  in  E-­‐cadherin  produces  a  30%  increase  
in   functional   tethering   between   coupled   -­‐cells.   The   relationship   between   the   CaR   and  
E-­‐cadherin   is   consistent  with  data   from  other   cell   types.   In   colonic   cells,   regulation  of  E-­‐
cadherin  and  -­‐catenin  was  found  dependent  on  CaR  expression  and  function  [37],  whilst  
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inactivation  of  the  CaR  inhibited  E-­‐cadherin-­‐mediated  cell-­‐cell  adhesion  in  human  epidermal  
keratinocytes   [38],   further  supporting  our  hypothesis   that   the   link  between  CaR  function  
and  AJ  proteins  can  sustain/improve  function.
In  addition  to  promoting  cell-­‐cell  adhesion,  chronic  activation  of  the  CaR  also  increased  
the  expression  of  the  L-­‐type  voltage-­‐dependent  calcium  channel  (VDCC).  Essential  for  insulin  
secretion,  these  channels  permit  Ca2+-­‐entry  ahead  of  nutrient-­‐evoked  exocytosis  in  the  -­‐cell.  
Spatial  interactions  between  voltage  dependent  calcium  channels  and  the  CaR  have  recently  
been  suggested  to  be  important  in  the  ϐirst  phase  of  insulin  secretion  from  -­‐cells  [39],  and  
the   increased  CaR-­‐evoked  expression   seen   in  our   study   could  explain   the   increase   in   the  
basal-­‐to-­‐peak   amplitude   of   secretogue-­‐evoked   changes   in   [Ca2+]i   in   response   to   both   the  
purinergic  agonist  ATP,  or  sulphonylurea  activation  of  the  K+ATP  channel  by  tolbutamide.  
There  are  a  number  of  studies  from  diverse  cell  types  that  suggest  a  role  for  the  CaR  
in   regulating   cell   proliferation,   including  work   in   ϐibroblasts   [40],   astrocytoma   [41],   and  
osteoblasts   [42].  The   low  mitotic   index  of  primary  -­‐cells   leads   to  considerable   technical  
difϐiculties   in   measuring   -­‐cell   proliferation   in   islets.   Previous   studies   demonstrate   that  
although  MIN6  cells  are  transformed,  their  proliferative  capacity  is  regulated  by  extracellular  
signals,   validating   these   clonal   -­‐cells   as   a   representative   experimental   model   of   -­‐cell  
proliferation  [43-­‐46].  Elevated  [Ca2+]e  can  activate  p38  and  p42/44  MAP  kinases  [27,  47]  and  
increase  cell  proliferation  [48].  In  addition  to  the  eﬀect  of  chronic  activation  of  the  CaR  on  
cell-­‐cell-­‐adhesion  we  have  also  shown  that  speciϐic  activation  of  the  CaR  by  the  calcimiemtic  
R568,   enhances   MEK-­‐dependent   proliferation   of   -­‐cells   at   physiologically   appropriate  
concentrations  of  extracellular  calcium.  
Conclusion
In  the  current  study  we  have  provided  compelling  evidence  that  activation  of  the  calcium-­‐
sensing   receptor   increases   expression   of   the   epithelial   (E)   adhesion   protein   E-­‐cadherin  
and   increases   functional   tethering  between  -­‐cells.  The   increase   in  cell-­‐cell   interaction   is  
mirrored  by  an  increase  in  the  expression  of  the  L-­‐type  VDCC  and  augmented  secretagogue-­‐
evoked  changes  in  [Ca2+]i.  Together,  these  ϐindings  could  help  explain  how  local  changes  in  co-­‐
released  calcium  activate  the  CaR  on  neighbouring  cells  to  help  propagate  and  synchronise  
activity  within  the  intact  islet  to  help  ensure  efϐicient  and  appropriate  insulin  secretion.
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